20 June 2026 · 8 min read
Best Practices for Storage and Handling of Lyophilised Peptide Reference Materials
If you work with peptide reference materials, how you store and handle them has a direct impact on whether your batches stay stable and your data stays reproducible. This guide covers practical storage and handling practices for lyophilised peptide reagents in a research setting, along with documentation habits that support traceability and quality.
Why storage matters for peptide materials
Peptides are sensitive to their environment. Heat, light, moisture and repeated temperature changes can all contribute to degradation over time.
Good storage is not about chasing perfection. It is about:
- Keeping the physical and chemical properties of the material as close as possible to the state described in the COA.
- Reducing variability between experiments that use the same batch.
- Making it easier to explain results when you write up or respond to reviewers.
For research materials, consistency is the goal.
Understanding lyophilised peptide format
Many peptide reference materials are supplied as lyophilised powders. This means water has been removed under vacuum to produce a dry solid that is generally more stable than a solution.
Lyophilised peptides are typically:
- Described as “white to off-white powder” on the COA.
- Stored in sealed vials to protect them from moisture and contamination.
- More stable in the dry state than after reconstitution into solution.
Even in lyophilised form, they are not immune to degradation. Long-term storage conditions and handling practices still matter.
Recommended storage conditions
Always follow the storage instructions on the COA and product label first. Where those are unclear, general good practice for peptide reference materials includes:
Temperature
Many peptide powders are stored either refrigerated (2–8 °C) or frozen (−20 °C), depending on the peptide and supplier guidance.
Avoid leaving vials at room temperature for extended periods, especially in warm or humid environments.
Light protection
Store vials in opaque containers or in a dark area of the fridge or freezer. Light can contribute to degradation for some compounds.
Moisture control
Keep vials tightly sealed. Where possible, store with desiccant in the outer container to reduce humidity exposure when the fridge or freezer is opened and closed.
Avoid repeated freeze–thaw cycles
Once a vial has been taken out of cold storage and allowed to warm, it is best practice to aliquot or reconstitute only what you need and return the remainder promptly, rather than cycling the same vial repeatedly.
If you have a critical or expensive batch, it is reasonable to treat it as a controlled item: log where it is stored, who can access it, and when it is removed from storage.
Handling lyophilised powders in the lab
When you take a vial of lyophilised peptide out of storage, a few simple habits help maintain quality and traceability:
Allow the vial to reach room temperature before opening
This reduces condensation forming inside the vial when you open it in a humid lab environment.
Work in a clean area
Use a clean bench or designated area, with clean gloves and tools, to minimise contamination risk.
Minimise time outside storage
Plan your work so the vial is open only for as long as needed. Return it to the correct storage temperature promptly after use.
Avoid unnecessary exposure to air and light
Keep the vial capped when not actively working with it, and avoid leaving it in bright light.
These steps are basic, but they make a real difference when you are trying to reproduce results over months using the same batch.
Reconstitution: principles and documentation
Reconstitution practices will vary depending on your protocol, but some general principles apply:
Choose an appropriate solvent
Common options include water, buffered solutions, or dilute acid, depending on peptide solubility and experimental needs. Follow method documentation rather than guessing.
Record concentrations accurately
Note the exact mass of peptide, the volume of solvent used, and the resulting concentration in your lab records. This is critical for downstream calculations and for comparing results across experiments.
Label solution containers clearly
Include peptide name, batch number, concentration, solvent, date of preparation, and who prepared it. This supports traceability if you need to revisit an experiment later.
Define solution storage conditions
Many peptide solutions are stored refrigerated or frozen, with clear limits on how long they are considered stable in your setting. Document these limits in your internal SOPs.
Even if you are not running a formal quality system, treating reconstituted solutions as controlled items makes your data more defensible.
Documentation and traceability habits
Storage and handling are only half the story. The other half is how you record what you did.
For each batch of peptide reference material, a simple record might include:
- Batch or lot number and supplier
- COA reference and storage location (fridge or freezer, which unit)
- Date received and who accepted it
- Dates when the vial was removed from storage and for what purpose
- Reconstitution details: solvent, concentration, date, and person
- Any observations about appearance or behaviour that differ from the COA description
You do not need a full LIMS to do this. A well-structured spreadsheet or simple database, with one row per batch and clear columns for these fields, is enough to start. Over time, this becomes a valuable resource when you are troubleshooting or writing up.
Common pitfalls to avoid
A few mistakes come up repeatedly in research settings:
Leaving vials at room temperature for days
Particularly in warm labs or during shipping delays, this can accelerate degradation.
Storing everything at one temperature without checking guidance
Some peptides are more stable frozen, others are fine refrigerated. Ignoring supplier or COA guidance defeats the purpose of having that documentation.
Reconstituting large volumes and storing them indefinitely
Solutions are generally less stable than lyophilised powders. Without clear stability limits in your records, you risk using degraded material and wondering why results have drifted.
No link between experiments and batch numbers
If you cannot say which batch of peptide was used in a given experiment, you cannot assess whether batch variation or storage issues are contributing to your results.
Avoiding these issues is mostly about discipline and simple records, not expensive infrastructure.
Research-use-only and regulatory context
This guide is written for researchers handling peptide materials as laboratory reagents, not as medicines or for personal administration.
In the UK, peptides supplied as research-use-only materials are distinct from medicinal products regulated by the MHRA. How they are stored, handled and documented should reflect their role as research tools, not as clinical products.
Nothing in this article is medical advice, and none of it should be interpreted as guidance for human or veterinary use. Staying within the RUO framing is important both for compliance and for maintaining a clear boundary between research materials and regulated medicines.